Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral vs intravenous dexmedetomidine with scalp nerve block in craniotomy
ChiCTR2000041360Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in Intracranial mass lesion (IML) and cerebrovascular disease (2 arms), sponsored by Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University. Primary endpoints: Blood pressure, Heart rate and 2 more. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Intracranial mass lesion (IML)cerebrovascular disease
Beyond the preview
Go deeper on ChiCTR2000041360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041360.